College leaders advocate for allergists and patients on Capitol Hill
Strike Force members spent three days on Capitol Hill meeting with members or legislative assistants in more than 25 Congressional offices.
AMA and MGMA back allergists’ call for an applicable MIPS Value Pathway
In the CMS 2027 Proposed QPP Rule, CMS proposed retiring the traditional MIPS reporting option after the 2028 performance period.
Allergists are off to Washington again
This week, a group of allergists will meet in Washington D.C. for the College’s 2026 Advocacy “Strike Force 2.0” on Capitol Hill.
ACAAI urges CMS to protect allergy practices
Medicare policy must reflect how allergy care is actually delivered and must not create new barriers for small and independent practices.
Making the case for fair allergy immunotherapy policy
The comment period for the proposed 2027 Medicare Physician Fee Schedule closed Sept. 14, and ACAAI made sure the voice of allergy was heard.
UHC touts prior authorization relief
A careful review of the codes finds little that will reduce the everyday administrative burden faced by allergists.
Medicare Advantage appeals process explained
To effectively advocate for their patients and to secure appropriate reimbursement, clinicians must understand the MA appeals framework.
Help us get fair payment for allergy extracts
Together, we and our partners have successfully persuaded Medicare to cover the buildup phase of allergy shots.
The 1% myth
Recent headlines suggest (incorrectly) that prior authorization is no longer the obstacle it once was.
CMS unveils the proposed 2027 Medicare physician fee schedule
CMS has responded to years of ACAAI advocacy by requesting public input on modernizing its allergy immunotherapy policies for CPT code 95165.
… results in Advocacy Resources.
